Stockreport

BDRX: Initiating Coverage of Biodexa Pharmaceuticals; A Deep Value Oncology Platform Built Around Two High-Conviction Areas [Yahoo! Finance]

Biodexa Pharmaceuticals plc - American Depositary Shares  (BDRX) 
PDF We are initiating coverage of Biodexa Pharmaceuticals, PLC (NASDAQ: BDRX) with a valuation of $7.00. Biodexa is a clinical-stage GI oncology company focused on developi [Read more]